475 studies found for:    Open Studies | "Carcinoma, Hepatocellular"
Show Display Options
Rank Status Study
21 Recruiting Sorafenib and TRC105 in Hepatocellular Cancer
Conditions: Hepatoma;   Liver Neoplasms;   Adenoma, Liver Cell;   Carcinoma, Hepatocellular;   Liver Neoplasms, Experimental
Interventions: Drug: TRC 105;   Drug: Sorafenib
22 Recruiting A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatoma;   Liver Cell Carcinoma
Interventions: Device: DEB-TACE;   Drug: Sorafenib
23 Unknown  Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients
Conditions: Cirrhosis With Hepatocellular Carcinoma;   Cirrhosis Without Hepatocellular Carcinoma
Interventions: Biological: Serum, plasma and DNA samples;   Procedure: Radiological exploration by CT scan or MRI
24 Not yet recruiting Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
Conditions: Fibrolamellar Hepatocellular Carcinoma;   Hepatocellular Carcinoma (Fibrolamellar Variant);   Hepatocellular Carcinoma
Interventions: Procedure: living related donor partial liver transplantation;   Radiation: Total body irradiation;   Procedure: Bone marrow transplant from same donor;   Drug: Cyclophosphamide;   Drug: Mesna;   Drug: Filgrastim;   Drug: Tacrolimus;   Drug: mycophenolate mofetil;   Drug: Prednisone;   Drug: Antithymocyte globulin;   Drug: fludarabine
25 Recruiting A Study of LY2157299 in Participants With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: LY2157299;   Drug: Sorafenib
26 Not yet recruiting MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Marker, Biological
27 Unknown  Circulating Tumor Cells for Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Neoplasm Circulating Cells
28 Recruiting Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPase
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Huachansu;   Other: TACE
29 Unknown  A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Lipotecan® (TLC388)
30 Not yet recruiting Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation
Conditions: Carcinoma, Hepatocellular;   Neoplastic Cells, Circulating
Interventions: Procedure: TACE;   Drug: Epirubicin;   Drug: lipiodol
31 Recruiting Phase I/II Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Biological: OBP-301
32 Recruiting Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)
Conditions: Carcinoma, Hepatocellular;   Secondary
Interventions: Drug: Sorafenib;   Drug: Capecitabine;   Drug: Oxaliplatin
33 Recruiting TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Procedure: Thermal Ablation;   Drug: EADM;   Drug: Ultra-fluid lipiodol;   Other: Gelatin sponge articles
34 Recruiting Study of Apatinib After Systemic Therapy(Chemotherapy and/or Targeted Therapy) in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Apatinib;   Drug: Placebo
35 Recruiting A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult Participants With Hepatocellular Carcinoma (HCC)
Condition: Carcinoma, Hepatocellular
Intervention: Drug: RO7070179
36 Not yet recruiting Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Pembrolizumab;   Procedure: Peripheral Blood Sample (optional);   Genetic: Tumor Tissue Collection (optional)
37 Not yet recruiting Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC
Condition: Carcinoma, Hepatocellular
Interventions: Drug: TACE containing As2O3;   Drug: TACE containing placebo
38 Unknown  TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Recombinant Human Adenovirus Type 5 Injection;   Procedure: Transartery Chemoembolization
39 Unknown  Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Interventions: Procedure: Radiofrequency ablation;   Procedure: TACE
40 Recruiting Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence
Conditions: Adult Hepatocellular Carcinoma;   Recurrent Hepatocellular Carcinoma;   Adverse Reaction to Drug;   Vascular Endothelial Growth Factor Overexpression
Interventions: Drug: thalidomine;   Drug: tegafur-uracil

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years